Modus Therapeutics to initiate clinical development of sevuparin in sepsis and septic shock March 11, 2021
Lilly reports promising data from new phase III cohort of BLAZE-1 study in early COVID-19 March 11, 2021
Initial phase I data on tri-specific COVID-19 antiviral treatment ensovibep in healthy volunteers March 10, 2021
Ivermectin does not significantly improve the time to resolution of symptoms in mild COVID-19 March 9, 2021
RSS